Evaluation of an adjustment group forpeople with multiple sclerosis and lowmood: a randomized controlled trial
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Background: Mood problems affect many people with multiple sclerosis (MS). The aim was to evaluate the effectiveness of a group treatment based on cognitive behavioural principles. Methods: People with MS were screened on the General Health Questionnaire 12 (GHQ-12) and Hospital Anxiety and Depression Scale (HAD). Those identified with low mood were invited to take part in a randomized trial comparing the effect of attending an adjustment group with a waiting list control. Patients allocated to the adjustment group received six 2 h group treatment sessions. Outcomes were assessed 4 and 8 months after randomization, blind to group allocation. Results: Of the 311 patients identified, 221 (71%) met the criteria for low mood and 151 (68%) agreed to take part. Hierarchical regression analyses were conducted to compare the two groups, correcting for baseline mood and disability. At 4 months, group allocation alone was a significant predictor of the primary outcome measure, the GHQ-12. At 8 months, group allocation alone was no longer a significant predictor for GHQ-12 scores, but it was when baseline GHQ-12 and Guy’s Neurological Disability Scale scores were controlled for. Comparison of the area under the curve revealed significant differences between the groups for GHQ-12 ( p = 0.003), HAD Anxiety ( p = 0.013), HAD Depression ( p = 0.004), Beck Depression Inventory ( p = 0.001), MS Self-efficacy ( p = 0.037) and MS Impact Scale Psychological ( p = 0.012). Conclusion: Patients receiving treatment were less distressed and had less depression and anxiety. There was some evidence of improved self-efficacy and a reduction of the impact of MS on people’s lives.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure
Hobart, J. (2001) · Brain · doi:10.1093/brain/124.5.962 · Cited by 1,120
Depression in multiple sclerosis: a review
Siegert, R. J. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054635 · Cited by 718
Beck Depression Inventory-II (BDI-II)
Bortnick, K. (2024) · Occupational Therapy Assessments for Older Adults · doi:10.4324/9781003525288-77 · Cited by 491
Mohr, D. C., Boudewyn, A. C., Goodkin, D. E., Bostrom, A., & Epstein, L. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.6.942 · Cited by 334
The Goldman Consensus statement on depression in multiple sclerosis
Goldman Consensus Group (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1162oa · Cited by 329
The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis
Sharrack, B., & Hughes, R. A. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500406 · Cited by 293
Purssell, E. (2013) · Cited by 284
Psychological interventions for multiple sclerosis.
Thomas, P. W., Thomas, S., Hillier, C., Galvin, K., & Baker, R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004431.pub2 · Cited by 271
Research works printed but not linked: 2
- National Institute for Health and Clinical Excellence, 2009, NICE Clinical Guideline 91
- Domenech CL, 1999, Mult Scler, 5, S144
Cited by
Fiest, K. M., Walker, J. R., Bernstein, C. N., Graff, L. A., Zarychanski, R., Abou-Setta, A. M., Patten, S. B., Sareen, J., Bolton, J. M., Marriott, J. J., et al. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.10.004 · Cited by 198
“Two trials measured physical and mental aspects of quality of life (Ehde et al., 2008; Forman and Lincoln, 2010), while a third trial used an overall quality of life measure (Lincoln et al., 2011).”
InfluentialHind, D., Cotter, J., Thake, A., Bradburn, M., Cooper, C., Isaac, C., & House, A. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-5 · Cited by 180
“A median of 45% (range 12% [30] to 71% [44]) of those approached about the study screened eligible (with the remainder in some studies refusing as well as failing screening).”
BackgroundMethodResultInfluentialDepression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment
Solaro, C. M., Gamberini, G., & Masuccio, F. G. (2018) · CNS Drugs · doi:10.1007/s40263-018-0489-5 · Cited by 197
Thomas, S. A., Walker, M. F., Macniven, J. A., Haworth, H., & Lincoln, N. B. (2013) · Clinical Rehabilitation · doi:10.1177/0269215512462227 · Cited by 149
Self-citationDistress improves after mindfulness training for progressive MS: a pilot randomised trial
Bogosian, A., Chadwick, P., Windgassen, S., Norton, S., McCrone, P., Mosweu, I., Silber, E., & Moss-Morris, R. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515576261 · Cited by 135
Metadata
- Authors
- Lincoln, N. B., Yuill, F., Holmes, J., Drummond, A. E., Constantinescu, C. S., Armstrong, S., & Phillips, C.
- Affiliations
- University of Nottingham (GB)
- Swansea University (GB)
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2011-10
- Volume
- 17
- Issue
- 10
- Pages
- 1250-1257
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2141697545
- Cited by
- 73
- References
- 20
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 12 · 2019: 6 · 2018: 6 · 2017: 4 · 2016: 7 · 2015: 6 · 2014: 5 · 2013: 6 · 2012: 6
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Multiple Sclerosis Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Multiple Sclerosis Society
- University of Nottingham
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- multiple sclerosis, depressive mood, depression, anxiety, group therapy, cognitive behavioral therapy, self-efficacy, psychological distress, disability
- MeSH terms
- Adult, Affect, Depression, Humans, Middle Aged, Multiple Sclerosis, ROC Curve, Cognitive Behavioral Therapy, Area Under Curve
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of an adjustment group forpeople with multiple sclerosis and lowmood: a randomized controlled trial. https://app.cochat.ai/papers/10.1177/1352458511408753
- The paper
- Lincoln, N. B., Yuill, F., Holmes, J., Drummond, A. E., Constantinescu, C. S., Armstrong, S., & Phillips, C. (2011). Evaluation of an adjustment group forpeople with multiple sclerosis and lowmood: a randomized controlled trial. Multiple Sclerosis Journal. https://doi.org/10.1177/1352458511408753
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.